Streetbeat News

Revenues

HOOK

Analysts have mixed views on HOOKIPA Pharma (NASDAQ:HOOK), with recent ratings ranging from bullish to bearish. The average 12-month price target is $5.38, down from $6.25. The company's financial performance shows a revenue decline of -5.38% and a net margin of -335.06%, indicating challenges despite a strong market capitalization and ROE. Analysts' adjustments reflect changing market conditions and company performance.

Portfolio Pulse from Benzinga Insights

April 26, 2024 | 12:00 pm

APPF

AppFolio's stock price increased following the announcement of its Q1 financial results, which exceeded expectations. Additionally, the company has uplifted its revenue guidance for FY24, surpassing previous estimates.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:57 am

HCA

HCA Healthcare has reaffirmed its revenue guidance for 2024, projecting revenues to be in the range of $67.75 billion to $70.25 billion. This projection aligns closely with the consensus estimate of $69.12 billion.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:34 am

BTCY

Biotricity announces high demand for its Biotres Pro, a 3-channel patch-like ECG, expected to increase subscription prices by over 32% and revenue by up to 10% from sales to existing customers through 2025. The initial production run has sold out, with pre-orders for the next run scheduled to ship by the end of May.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:29 am

CMG

PBJ

VTI

Chipotle Mexican Grill Inc (NYSE:CMG) temporarily requested employees to avoid ordering chicken to preserve supply for customers due to high demand, particularly after the reintroduction of chicken al pastor. The directive, which was not a mandate, has been lifted within a week. This decision came amidst reports of increased sales and a successful first quarter, with revenue up 14.1% year-over-year and adjusted earnings surpassing analyst estimates. The stock has seen over a 54% gain in the last 12 months. Investors can also gain exposure to CMG through ETFs like Vanguard Total Stock Market ETF (NYSE:VTI) and Invesco Food & Beverage ETF (NYSE:PBJ).

Portfolio Pulse from Shivani Kumaresan

April 26, 2024 | 11:20 am

CHTR

Charter Communications reported a decrease of 72,000 in total residential and SMB Internet customers, totaling 30.5 million as of March 31, 2024. Conversely, their mobile lines saw an increase of 486,000, reaching 8.3 million. Overall, Charter had 32.0 million residential and SMB customer relationships, excluding mobile-only relationships.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:08 am

CHTR

Charter Communications reported a decrease of 72,000 in Q1 residential and SMB Internet customers, but saw an increase of 486,000 in mobile lines. Total revenue for the quarter was $13.7 billion, a 0.2% increase year-over-year, with significant growth in residential mobile service and Internet revenue.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:06 am

VRTS

Virtus Investment Partners (VRTS) reported Q1 2024 earnings of $5.41 per share, meeting consensus estimates and marking a 28.81% increase from the previous year. Sales reached $222.042M, exceeding estimates by 8.40% and showing a 12.21% increase year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:05 am

SLCA

US Silica Holdings (NYSE:SLCA) reported Q1 2024 adjusted EPS of $0.20, meeting analyst estimates, but missed sales forecasts with $325.9M versus the expected $336.591M, a 3.18% miss and a 26.31% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:03 am

CL

Colgate-Palmolive reported Q1 sales of $5.065 billion, surpassing the analyst consensus estimate of $4.956 billion by 2.20% and marking a 6.18% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 10:56 am